assessed KDM6A, a member of the mixed-lineage-leukemia (MLL2) H3K4 methyltransferase complex, and reported that expression of KDM6A protein was higher in NSCLC tissues than in corresponding para-cancer tissues and that higher expression was associated with poor prognosis (76). Here, KDM6A is linked to cancer.